Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:626-635
Published online before print August 24, 2006, doi: 10.1161/01.RES.0000243208.59795.d8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/6/626    most recent
01.RES.0000243208.59795.d8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallhuber, M.
Right arrow Articles by Ritter, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallhuber, M.
Right arrow Articles by Ritter, O.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Other myocardial biology
Right arrow Congestive
(Circulation Research. 2006;99:626.)
© 2006 American Heart Association, Inc.


Integrative Physiology

Inhibition of Nuclear Import of Calcineurin Prevents Myocardial Hypertrophy

Matthias Hallhuber, Natalie Burkard, Rongxue Wu, Mamta H. Buch, Stefan Engelhardt, Lutz Hein, Ludwig Neyses, Kai Schuh, Oliver Ritter

From the Department of Medicine I (M.H., N.B., R.W., O.R.); Institute of Physiology (K.S.); and Rudolf-Virchow-Center (S.E.), DFG-Research Center for Experimental Biomedicine, University of Wuerzburg, Germany; University Department of Medicine (M.H.B., L.N.), Manchester Royal Infirmary, UK; and the Institute of Experimental and Clinical Pharmacology and Toxicology (L.H.), University of Freiburg, Germany.

Correspondence to Oliver Ritter, MD, Department of Medicine I, University of Wuerzburg, Josef Schneider Str. 2, 97080 Wuerzburg, Germany. E-mail Ritter_O{at}klinik.uni-wuerzburg.de

The time that transcription factors remain nuclear is a major determinant for transcriptional activity. It has recently been demonstrated that the phosphatase calcineurin is translocated to the nucleus with the transcription factor nuclear factor of activated T cells (NF-AT). This study identifies a nuclear localization sequence (NLS) and a nuclear export signal (NES) in the sequence of calcineurin. Furthermore we identified the nuclear cargo protein importinß1 to be responsible for nuclear translocation of calcineurin. Inhibition of the calcineurin/importin interaction by a competitive peptide (KQECKIKYSERV), which mimicked the calcineurin NLS, prevented nuclear entry of calcineurin. A noninhibitory control peptide did not interfere with the calcineurin/importin binding. Using this approach, we were able to prevent the development of myocardial hypertrophy. In angiotensin II-stimulated cardiomyocytes, [3H]-leucine incorporation (159%±9 versus 111%±11; P<0.01) and cell size were suppressed significantly by the NLS peptide compared with a control peptide. The NLS peptide inhibited calcineurin/NF-AT transcriptional activity (227%±11 versus 133%±8; P<0.01), whereas calcineurin phosphatase activity was unaffected (298%±9 versus 270%±11; P=NS). We conclude that calcineurin is not only capable of dephosphorylating NF-AT, thus enabling its nuclear import, but the presence of calcineurin in the nucleus is also important for full NF-AT transcriptional activity.


Key Words: angiotensin II • calcineurin • gene regulation • hypertrophy • NF-AT • nuclear-localizing signals




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. D. Bootman, C. Fearnley, I. Smyrnias, F. MacDonald, and H. L. Roderick
An update on nuclear calcium signalling
J. Cell Sci., July 15, 2009; 122(14): 2337 - 2350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Das, S. Gupta, A. Vasanji, Z. Xu, S. Misra, and S. Sen
Nuclear Co-translocation of Myotrophin and p65 Stimulates Myocyte Growth: REGULATION BY MYOTROPHIN HAIRPIN LOOPS
J. Biol. Chem., October 10, 2008; 283(41): 27947 - 27956.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Jeong, J. M. Kim, H. Cha, J. G. Oh, J. Park, S.-H. Yun, E.-S. Ju, E.-S. Jeon, R. J. Hajjar, and W. J. Park
PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin-NFAT Signaling
Circ. Res., March 28, 2008; 102(6): 711 - 719.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Frank, C. Kuhn, M. van Eickels, D. Gehring, C. Hanselmann, S. Lippl, R. Will, H. A. Katus, and N. Frey
Calsarcin-1 Protects Against Angiotensin-II Induced Cardiac Hypertrophy
Circulation, November 27, 2007; 116(22): 2587 - 2596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. S. Philips, J. C. Kwok, and B. H. Chong
Analysis of the Signals and Mechanisms Mediating Nuclear Trafficking of GATA-4: LOSS OF DNA BINDING IS ASSOCIATED WITH LOCALIZATION IN INTRANUCLEAR SPECKLES
J. Biol. Chem., August 24, 2007; 282(34): 24915 - 24927.
[Abstract] [Full Text] [PDF]